I'd like to send this letter by  http://egotastic.in.net egotastic  The move has fueled speculation that Glaxo, which owns 27percent of Theravance, may eventually buy Theravance's mostlucrative products. (Reporting by Toni Clarke in Washington; Editing by CarolBishopric and Richard Chang)